4th Quarter - Report

SOCIETY FOR NEUROSCIENCE for SOCIETY FOR NEUROSCIENCE

Firm
Client
Income
—
Expenses
$92,563
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Immigration IMM

Communications opposing the Administrations proposed travel restrictions as applied to participants in scientific meetings.

LobbyistCovered position, as disclosed
ALLEN SEGAL —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Office of Management & Budget (OMB)

Budget/Appropriations BUD

Advocacy efforts related to FY18 funding for National Institutes of Health and the National Science Foundation. Additional advocacy efforts to support completion of FY18 appropriations and raising the budget sequestration caps to fully fund medical research.

LobbyistCovered position, as disclosed
ALLEN SEGAL —

Contacted: Natl Institutes of Health (NIH); White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE

Education EDU

Communication and outreach concerning the impacts of taxing graduate student tuition waivers and university endowments included in the Tax Cuts and Jobs Act (HR 1).

LobbyistCovered position, as disclosed
ALLEN SEGAL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Natl Institutes of Health (NIH); Office of Management & Budget (OMB)

Bills named: H.R. 1 (115th)

Animals ANI

Communication concerning the responsible use of animal models in biomedical research. Advocacy opposing H.R. 3197, the Preventing Unkind and Painful Procedures and Experiments on Respected Species (PUPPERS) Act of 2017, referred to the House Veterans Affairs Committee.

LobbyistCovered position, as disclosed
ALLEN SEGAL —

Contacted: SENATE; Office of Management & Budget (OMB); White House Office; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 3197 (115th)

Medical/Disease Research/Clinical Labs MED

Outreach and communication on the unintended effects of NIH's proposed definition of "clinical trials" including the implications for for basic human neuroscience research and grantmaking. Communication concerning policies on acceptable language to be used by CDC.

LobbyistCovered position, as disclosed
ALLEN SEGAL —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; White House Office; Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.